SofWave Medical Ltd.
SOFWF
$12.75
$1.8516.97%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 46.92% | 36.05% | 25.53% | 18.92% | 18.56% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 46.92% | 36.05% | 25.53% | 18.92% | 18.56% |
| Cost of Revenue | 51.42% | 35.03% | 19.68% | 10.68% | 10.01% |
| Gross Profit | 45.49% | 36.39% | 27.49% | 21.74% | 21.54% |
| SG&A Expenses | 21.35% | 22.69% | 20.75% | 19.73% | 12.06% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.74% | 23.48% | 18.29% | 14.44% | 8.45% |
| Operating Income | 291.84% | 171.68% | 94.72% | 31.27% | 55.19% |
| Income Before Tax | 241.42% | 133.16% | 66.20% | 20.51% | 50.91% |
| Income Tax Expenses | -49.18% | 137.50% | 24.32% | 769.57% | 2,962.50% |
| Earnings from Continuing Operations | 220.70% | 116.22% | 60.51% | 13.81% | 45.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 220.70% | 116.22% | 60.51% | 13.81% | 45.08% |
| EBIT | 291.84% | 171.68% | 94.72% | 31.27% | 55.19% |
| EBITDA | 479.41% | 284.79% | 152.67% | 42.84% | 66.63% |
| EPS Basic | 215.77% | 115.03% | 60.28% | 14.73% | 45.34% |
| Normalized Basic EPS | 235.72% | 131.48% | 65.86% | 21.34% | 51.12% |
| EPS Diluted | 194.84% | 106.27% | 56.72% | 13.91% | 44.80% |
| Normalized Diluted EPS | 217.59% | 123.72% | 61.47% | 21.34% | 51.12% |
| Average Basic Shares Outstanding | 3.07% | 2.39% | 1.67% | 1.09% | 0.53% |
| Average Diluted Shares Outstanding | 12.66% | 8.66% | 4.72% | 1.09% | 0.53% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |